Sign in

CIK 0001099800

  • Large accelerated filer

Edwards Lifesciences Corp

Sign in to watch
Ticker
EW
Exchange
NYSE
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
364316614
Phone
+1 949-250-2500
Business address
ONE EDWARDS WAY, IRVINE, CA, 92614
Former names
CVG CONTROLLED INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$10,886,105
in 9 filings, $7.6M under 10b5-1 plans

Net −$10,886,105. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-02-13 Szyman Catherine M. CVP, Critical Care Exercise or conversion · Employee Stock Option (Right to Acquire) −20,000 27,000
2024-02-13 BOBO DONALD E JR CVP,Strategy/Corp Development Exercise or conversion 10b5-1 +11,000 $36.75 $404K 50,502.69
2024-02-13 BOBO DONALD E JR CVP,Strategy/Corp Development Sale 10b5-1 −470 $86.35 $41K 50,032.69
2024-02-13 BOBO DONALD E JR CVP,Strategy/Corp Development Sale 10b5-1 −10,530 $85.81 $904K 39,502.69
2024-02-13 BOBO DONALD E JR CVP,Strategy/Corp Development Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 −11,000 27,000
2024-02-12 SELLERS ROBERT W.A. SVP, Corporate Controller Exercise or conversion +12,210 $36.75 $449K 25,297.18
2024-02-12 SELLERS ROBERT W.A. SVP, Corporate Controller Sale −12,210 $87.00 $1.1M 13,087.18
2024-02-12 SELLERS ROBERT W.A. SVP, Corporate Controller Exercise or conversion · Employee Stock Option (Right to Acquire) −12,210 0
2024-02-08 STONE HEISZ LESLIE Director Exercise or conversion +7,056 $36.86 $260K 34,036
2024-02-08 STONE HEISZ LESLIE Director Sale −7,056 $86.45 $610K 26,980
2024-02-08 STONE HEISZ LESLIE Director Exercise or conversion · Director Stock Option (Right to Acquire) −7,056 0
2024-02-05 MUSSALLEM MICHAEL A Director Exercise or conversion 10b5-1 +29,350 $36.75 $1.1M 33,835.82
2024-02-05 MUSSALLEM MICHAEL A Director Sale 10b5-1 −1,000 $89.61 $90K 32,835.82
2024-02-05 MUSSALLEM MICHAEL A Director Sale 10b5-1 −6,422 $88.63 $569K 26,413.82
2024-02-05 MUSSALLEM MICHAEL A Director Sale 10b5-1 −9,761 $86.44 $844K 16,652.82
2024-02-05 MUSSALLEM MICHAEL A Director Sale 10b5-1 −12,167 $87.55 $1.1M 4,485.82
2024-02-05 MUSSALLEM MICHAEL A Director Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 −29,350 88,050
2024-02-01 Ullem Scott B. CVP, Chief Financial Officer Exercise or conversion 10b5-1 +7,255 $36.75 $267K 26,503
2024-02-01 Ullem Scott B. CVP, Chief Financial Officer Sale 10b5-1 −7,255 $78.29 $568K 19,248
2024-02-01 Ullem Scott B. CVP, Chief Financial Officer Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 −7,255 21,760

Page 30 of 43 · 841 trades